DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

The Top 10 Blockbuster Expected to be Launched by 2019

 

The Top 10 Blockbuster Expected to be Launched by 2019

Who will be the next Prozac or Viagra? In the latest white paper from DRG, our experts predict the top 10 blockbuster drugs expected to be launched by 2019. Here’s a hint… oncology and central nervous system therapies are expected to lead the industry. Find out if your brand made the Top 10.

Questions answered in this white paper include:

  • Will the shift toward targeted therapies lead to a decrease in the number of blockbusters?
  • Are the types of blockbusters expected to change over time?
  • What role will rare diseases play in bringing in revenue?
  • Will the blockbuster model be able to sustain growth for pharmaceutical companies?